ES388527A1 - Procedimiento para la preparacion de dipropilacetato de calcio destinado a aumentar el nivel sanguineo de calcio y afavorecer la recalcificacion en el organismo humano y ani- mal. - Google Patents
Procedimiento para la preparacion de dipropilacetato de calcio destinado a aumentar el nivel sanguineo de calcio y afavorecer la recalcificacion en el organismo humano y ani- mal.Info
- Publication number
- ES388527A1 ES388527A1 ES388527A ES388527A ES388527A1 ES 388527 A1 ES388527 A1 ES 388527A1 ES 388527 A ES388527 A ES 388527A ES 388527 A ES388527 A ES 388527A ES 388527 A1 ES388527 A1 ES 388527A1
- Authority
- ES
- Spain
- Prior art keywords
- calcium
- acetone
- under stirring
- blood
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title abstract 2
- 229910052791 calcium Inorganic materials 0.000 title abstract 2
- 239000011575 calcium Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 4
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 abstract 2
- 238000003756 stirring Methods 0.000 abstract 2
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 abstract 1
- 230000036765 blood level Effects 0.000 abstract 1
- 235000012255 calcium oxide Nutrition 0.000 abstract 1
- 239000000292 calcium oxide Substances 0.000 abstract 1
- PIZHURYFCSGTJX-UHFFFAOYSA-L calcium;2-propylpentanoate Chemical compound [Ca+2].CCCC(C([O-])=O)CCC.CCCC(C([O-])=O)CCC PIZHURYFCSGTJX-UHFFFAOYSA-L 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
- C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR707006583A FR2077918B1 (enExample) | 1970-02-24 | 1970-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES388527A1 true ES388527A1 (es) | 1974-04-16 |
Family
ID=9051186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES388527A Expired ES388527A1 (es) | 1970-02-24 | 1971-02-23 | Procedimiento para la preparacion de dipropilacetato de calcio destinado a aumentar el nivel sanguineo de calcio y afavorecer la recalcificacion en el organismo humano y ani- mal. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3814812A (enExample) |
| BE (1) | BE762399A (enExample) |
| DE (1) | DE2105925C3 (enExample) |
| ES (1) | ES388527A1 (enExample) |
| FR (1) | FR2077918B1 (enExample) |
| GB (1) | GB1301973A (enExample) |
| NL (1) | NL7102255A (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4301176A (en) * | 1980-08-18 | 1981-11-17 | Warner-Lambert Company | Method of administering calcium valproate |
| FR2547499A1 (fr) * | 1983-06-15 | 1984-12-21 | Opochimiotherapie Lab | Medicaments contenant du dipropylacetate de calcium |
| IL72381A (en) * | 1983-07-20 | 1988-03-31 | Sanofi Sa | Pharmaceutical composition based on valproic acid |
| US4913906B1 (en) * | 1985-02-28 | 2000-06-06 | Yissum Res Dev Co | Controlled release dosage form of valproic acid |
| US5070710A (en) * | 1989-02-07 | 1991-12-10 | Sara Lee Corporation | Garment blank and method of making it |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス，インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| US7985756B2 (en) | 2005-10-21 | 2011-07-26 | Braincells Inc. | Modulation of neurogenesis by PDE inhibition |
| WO2007053596A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| WO2007134136A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| EP2068872A1 (en) | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20080188457A1 (en) * | 2007-02-02 | 2008-08-07 | Braincells, Inc. | Modulation of Neurogenesis with Biguanides and GSK3-beta Agents |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2266992A (en) * | 1939-03-15 | 1941-12-23 | American Cyanamid Co | Therapeutic composition |
-
1970
- 1970-02-24 FR FR707006583A patent/FR2077918B1/fr not_active Expired
-
1971
- 1971-02-02 BE BE762399A patent/BE762399A/xx unknown
- 1971-02-09 DE DE2105925A patent/DE2105925C3/de not_active Expired
- 1971-02-19 NL NL7102255A patent/NL7102255A/xx unknown
- 1971-02-23 US US00117950A patent/US3814812A/en not_active Expired - Lifetime
- 1971-02-23 ES ES388527A patent/ES388527A1/es not_active Expired
- 1971-04-19 GB GB2241371A patent/GB1301973A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2105925B2 (de) | 1974-04-04 |
| US3814812A (en) | 1974-06-04 |
| DE2105925A1 (enExample) | 1971-09-09 |
| DE2105925C3 (de) | 1974-11-21 |
| NL7102255A (enExample) | 1971-08-26 |
| BE762399A (fr) | 1971-08-02 |
| FR2077918B1 (enExample) | 1973-04-06 |
| GB1301973A (enExample) | 1973-01-04 |
| FR2077918A1 (enExample) | 1971-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU572201A3 (ru) | Способ получени метилового эфира 5-пропилтио-2-бензимидазолкарбаминовой кислоты | |
| BE791653A (fr) | Procede electrolytique de preparation de l'acide | |
| Garcia et al. | Studies of the tumorigenic effect in feeding of nitrosamino acids and of low doses of amines and nitrite to rats | |
| ES381894A1 (es) | Procedimiento para la preparacion de o-acil-lisegoles. | |
| US3814812A (en) | Medicament and method of increasing the calcium content of the blood | |
| IE41350L (en) | Substituted phenoxypropanolamines | |
| BE763091A (fr) | Procede de preparation d'acide naphtalene-monocarboxylique ou d'acide naphtalene-dicarboxylique | |
| GB807638A (en) | Substantially anhydrous ferrous fumarate and a method of preparing same | |
| ATE4169T1 (de) | Antacidum auf der basis von magnesium-aluminium- hydroxyd und seine herstellung. | |
| JPS567799A (en) | Novel pseudotrisaccharide* its manufacture and use as medicine | |
| ES373916A1 (es) | Procedimiento para la obtencion de monohidrato de carbonatosodico. | |
| SE7407882L (sv) | Sett att behandla vetskor innehallande blodkroppar. | |
| FR2446841A1 (fr) | Procede de preparation de 1a,3b-dihydroxy-d5-steroides | |
| OA04139A (fr) | Procédé de préparation de dérivés de l'acide 4-chloro-5-sulfamoyl-anthranilique. | |
| ES406450A1 (es) | Procedimiento para la preparacion del malato de arginina. | |
| SU529171A1 (ru) | Способ получени производных 1,8-оксазадекалонов-4 | |
| SU803861A3 (ru) | Способ получени соли памоиновойКиСлОТы и пилОКАРпиНА | |
| ES402328A1 (es) | Procedimiento para preparar 4-hidroxibenzodio-xol. | |
| ES428937A1 (es) | Un procedimiento mejorado para la purificacion de acido sulfurico acuoso. | |
| SU533380A1 (ru) | Способ повышени гипогликемической активности инсулина | |
| DE835146C (de) | Verfahren zur Herstellung von Theobromin-Calciumsalicylat | |
| US2478984A (en) | Medicinal preparation containing available calcium and phosphorus | |
| BE820267A (fr) | Procede pour la preparation d'acide p. isobutyle-hydratropique | |
| GB1305860A (enExample) | ||
| GB795941A (en) | New streptomycin salt |